Live Micron Technology Inc Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

25151
1
LadRx Corp LadRx Corporation Reports $1.6 Million Net Loss for Fiscal Year 2024, Faces Funding Challenges

Via official filing (AI summary) | about 1 year ago | 0 comments

25152
1
LIPELLA PHARMACEUTICALS INC. Lipella Pharmaceuticals Reports $5.02 Million Net Loss and $536,000 Revenue for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25153
1
COMMUNITY BANCORP /VT Community Bancorp Reports 10% Revenue Growth to $20.5 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25154
1
ATLANTIC INTERNATIONAL CORP. Atlantic International Corp Reports $135.5 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25155
1
STRATA Skin Sciences, Inc. STRATA Skin Sciences Reports $33.6M Revenue with Reduced Net Loss in 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25156
1
zSpace, Inc. zSpace Reports $38.1 Million Revenue for Fiscal Year 2024, Faces Challenges in Profitability

Via official filing (AI summary) | about 1 year ago | 0 comments

25157
1
CoinShares Bitcoin ETF CoinShares Valkyrie Bitcoin Fund Reports $826.1 Million NAV in First Year

Via official filing (AI summary) | about 1 year ago | 0 comments

25158
1
Roth CH Acquisition Co. Roth CH Acquisition Co. Reports Significant Decrease in Net Income for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25159
1
Perception Capital Corp. IV Perception Capital Corp. IV Reports Decrease in Net Income and Faces Uncertainty in Business Combination

Via official filing (AI summary) | about 1 year ago | 0 comments

25160
1
Horizon Space Acquisition I Corp. Horizon Space Acquisition I Corp. Reports Decrease in Net Income and Increased Operating Costs for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25161
1
PMGC Holdings Inc. Elevai Labs Reports 44% Revenue Growth but Increases Net Loss in Latest 10-K Filing

Via official filing (AI summary) | about 1 year ago | 0 comments

25162
1
374Water Inc. 374Water Inc. Reports 40% Revenue Decline and Increased Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25163
1
Direct Digital Holdings, Inc. Direct Digital Holdings Reports 60% Revenue Decline for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25164
1
BioRestorative Therapies, Inc. BioRestorative Therapies Reports $8.98 Million Net Loss, Revenue Growth to $401,000

Via official filing (AI summary) | about 1 year ago | 0 comments

25165
1
P3 Health Partners Inc. P3 Health Partners Reports $310.4 Million Net Loss and 18% Revenue Growth for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25166
1
Chenghe Acquisition II Co. Chenghe Acquisition II Co. Reports Financial Performance and Business Combination Agreement with Polibeli Group Ltd.

Via official filing (AI summary) | about 1 year ago | 0 comments

25167
1
HEALTHY CHOICE WELLNESS CORP. Healthy Choice Wellness Corp. Reports 24.5% Sales Growth and Strategic Changes for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25168
1
Whitehawk Therapeutics, Inc. Whitehawk Therapeutics Reports $63.7M Net Loss for 2024, Increases Revenue from FYARRO

Via official filing (AI summary) | about 1 year ago | 0 comments

25169
1
BioAtla, Inc. BioAtla Reports $69.7 Million Net Loss for Fiscal Year 2024, Highlights Strategic Improvements

Via official filing (AI summary) | about 1 year ago | 0 comments

25170
1
PROVECTUS BIOPHARMACEUTICALS, INC. Provectus Biopharmaceuticals Reports $4.76 Million Net Loss and Revenue Growth Amid Financial Challenges

Via official filing (AI summary) | about 1 year ago | 0 comments

25171
1
My Size, Inc. My Size, Inc. Reports 18.1% Revenue Growth to $8.26 Million, Despite Net Loss Reduction

Via official filing (AI summary) | about 1 year ago | 0 comments

25172
1
Sharps Technology Inc. Sharps Technology Reports $9.3 Million Net Loss for Fiscal Year 2024, Focuses on Product Expansion

Via official filing (AI summary) | about 1 year ago | 0 comments

25173
1
Aspira Women's Health Inc. Aspira Women's Health Reports $13.1 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25174
1
DURECT CORP DURECT Corporation Reports $8.3 Million Net Loss for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments

25175
1
TAO Synergies Inc. Synaptogenix Reports Increased Net Losses of $12.8 Million for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments